Preliminary Report on the Clinical Use of Tace (Chlorotrianisene) in Treatment of Prostatic Carcinoma

No AccessJournal of Urology1 May 1951Preliminary Report on the Clinical Use of Tace (Chlorotrianisene) in Treatment of Prostatic Carcinoma Parke G. Smith, T.W. Rush, and Arthur T. Evans Parke G. SmithParke G. Smith , T.W. RushT.W. Rush , and Arthur T. EvansArthur T. Evans View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)68567-7AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1951 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byCox R and Crawford E (2018) Estrogens in the Treatment of Prostate CancerJournal of Urology, VOL. 154, NO. 6, (1991-1998), Online publication date: 1-Dec-1995.Segal S, Marberger H and Flocks R (2018) Tissue Distribution of Stilbestrol Diphosphate: Concentration in Prostatic TissueJournal of Urology, VOL. 81, NO. 3, (474-478), Online publication date: 1-Mar-1959.Lynch K (2018) Significance of Adrenal Enlargement Caused by Estrogen TreatmentJournal of Urology, VOL. 73, NO. 4, (619-626), Online publication date: 1-Apr-1955.Wheeler J (2018) Advanced Carcinoma of the Prostate: An Unusual Case StudyJournal of Urology, VOL. 72, NO. 5, (934-938), Online publication date: 1-Nov-1954.Scardino P, Prince C and McGoldrick T (2018) Bilateral Adrenalectomy for Prostatic CancerJournal of Urology, VOL. 70, NO. 1, (100-109), Online publication date: 1-Jul-1953.Flocks R (2018) Treatment of Carcinoma of the ProstateJournal of Urology, VOL. 70, NO. 3, (491-498), Online publication date: 1-Sep-1953. Volume 65Issue 5May 1951Page: 886-889 Advertisement Copyright & Permissions© 1951 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Parke G. Smith More articles by this author T.W. Rush More articles by this author Arthur T. Evans More articles by this author Expand All Advertisement PDF downloadLoading ...